ARALEZ PHARMACEUTICALS INC. Comprehensive Income
ARALEZ PHARMACEUTICALS INC. reported Comprehensive Income of -$23.60 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-03-31 was -$23.60M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-12-31 was -$46.51M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-09-30 was -$18.87M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-06-30 was -$24.15M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$115.72M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$98.16M.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$37.78M, a 292.04% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was $19.68M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$23.60M 10-Q · filed 2018-05-08 | -$70.11M derived: sum of 2 quarters · filed 2018-05-08 | -$88.97M derived: sum of 3 quarters · filed 2018-05-08 | -$113.12M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | -$46.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$65.38M derived: sum of 2 quarters · filed 2018-03-14 | -$89.53M derived: sum of 3 quarters · filed 2018-03-14 | -$115.72M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$18.87M 10-Q · filed 2017-11-09 | -$43.01M derived: sum of 2 quarters · filed 2017-11-09 | -$69.21M 10-Q · filed 2017-11-09 | -$103.59M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$24.15M 10-Q · filed 2017-08-09 | -$50.34M 10-Q · filed 2017-08-09 | -$84.73M derived: sum of 3 quarters · filed 2018-05-08 | -$107.39M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$26.20M 10-Q · filed 2018-05-08 | -$60.58M derived: sum of 2 quarters · filed 2018-05-08 | -$83.24M derived: sum of 3 quarters · filed 2018-05-08 | -$100.27M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$34.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$57.05M derived: sum of 2 quarters · filed 2018-03-14 | -$74.07M derived: sum of 3 quarters · filed 2018-03-14 | -$98.16M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$22.66M 10-Q · filed 2017-11-09 | -$39.69M derived: sum of 2 quarters · filed 2017-11-09 | -$63.78M 10-Q · filed 2017-11-09 | -$77.10M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$17.03M 10-Q · filed 2017-08-09 | -$41.12M 10-Q · filed 2017-08-09 | -$54.44M derived: sum of 3 quarters · filed 2018-03-14 | -$62.59M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | -$24.09M 10-Q · filed 2017-05-09 | -$37.41M derived: sum of 2 quarters · filed 2018-03-14 | -$45.56M derived: sum of 3 quarters · filed 2018-03-14 | -$61.84M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$13.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$21.48M derived: sum of 2 quarters · filed 2018-03-14 | -$37.76M derived: sum of 3 quarters · filed 2018-03-14 | -$37.78M 10-K · filed 2018-03-14 |
| 2015-09-30 | -$8.15M 10-Q · filed 2016-11-08 | -$24.43M derived: sum of 2 quarters · filed 2016-11-08 | -$24.46M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | -$16.28M 10-Q · filed 2016-08-09 | -$16.31M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$28.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $19.68M 10-K · filed 2017-03-13 |